CR Bard, AngioDynamics Spar Over Timing Of Damages Trial
C.R. Bard and AngioDynamics have laid out different time frames on when a Delaware federal court should schedule a damages trial after a jury last month found AngioDynamics' implantable port products...To view the full article, register now.
Already a subscriber? Click here to view full article